20.92
4.65%
-1.02
Handel nachbörslich:
20.92
Syndax Pharmaceuticals Inc Aktie (SNDX) Neueste Nachrichten
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 3.7% - MarketBeat
MarketBeat
Can you now get a good deal on Syndax Pharmaceuticals Inc's shares? – US Post News - US Post News
US Post News
Syndax appoints Aleksandra Rizo to board of directors - Investing.com Canada
Investing.com Canada
Syndax Pharmaceuticals Welcomes New Board Member, Passes Resolutions - TipRanks.com - TipRanks
TipRanks
Ratio Revelations: Syndax Pharmaceuticals Inc (SNDX)'s Financial Metrics in the Spotlight – DWinneX - The Dwinnex
The Dwinnex
New York State Common Retirement Fund Sells 1842 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Defense World
(SNDX) Trading Advice - Stock Traders Daily
Stock Traders Daily
Syndax Pharmaceuticals, Inc. Forecasted to Earn Q2 2024 Earnings of ($0.96) Per Share (NASDAQ:SNDX) - MarketBeat
MarketBeat
There is no way Syndax Pharmaceuticals Inc (SNDX) can keep these numbers up – Sete News - SETE News
SETE News
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Increased to $40.00 by Analysts at Stifel Nicolaus - Defense World
Defense World
Syndax Pharmaceuticals (NASDAQ:SNDX) Given “Buy” Rating at HC Wainwright - Defense World
Defense World
B. Riley Equities Analysts Boost Earnings Estimates for Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Defense World
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Syndax Pharmaceuticals (SNDX) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
Are Medical Stocks Lagging Acer Therapeutics (ACER) This Year? - Yahoo Lifestyle Australia
Yahoo Lifestyle Australia
Cwm LLC Buys 1358 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Defense World
Citigroup Lowers Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $30.00 - MarketBeat
MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $40.00 Price Target at Stifel Nicolaus - MarketBeat
MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Posts Quarterly Earnings Results - MarketBeat
MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Reiterated by HC Wainwright - MarketBeat
MarketBeat
Syndax Pharmaceuticals stock target raised by Stifel By Investing.com - Investing.com Canada
Investing.com Canada
Here's Why Momentum in Syndax (SNDX) Should Keep going - Yahoo Movies UK
Yahoo Movies UK
Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference - PrimePublishers.com
PrimePublishers.com
Syndax Pharmaceuticals (SNDX) Outpaces Stock Market Gains: What You Should Know - Yahoo Singapore News
Yahoo Singapore News
Have Insiders Been Buying Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares This Year? - Yahoo Movies Canada
Yahoo Movies Canada
(SNDX) Investment Analysis and Advice - Stock Traders Daily
Stock Traders Daily
Syndax Pharmaceuticals (SNDX) Gains But Lags Market: What You Should Know - Yahoo Movies Canada
Yahoo Movies Canada
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Investing.com India
Investing.com India
Syndax Pharmaceuticals (SNDX) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
MarketBeat
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks Investment Research
Ratio Review: Analyzing Syndax Pharmaceuticals Inc (SNDX)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex
The Dwinnex
Ratio Review: Analyzing Syndax Pharmaceuticals Inc (SNDX)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex
The Dwinnex
Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum - Investing.com South Africa
Investing.com South Africa
Crinetics, Syndax stocks gain amid pitch at Sohn charity conference (NASDAQ:CRNX) - Seeking Alpha
Seeking Alpha
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA
Zacks Investment Research
SNDX Stock Quote Price and Forecast - CNN
CNN
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA - Yahoo Finance
Yahoo Finance
Syndax Pharmaceuticals Welcomes New CCO Steven Closter - TipRanks.com - TipRanks
TipRanks
Here's Why We're Not Too Worried About Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation - Yahoo Finance
Yahoo Finance
5 Biotech Stocks with Huge Potential - Insider Monkey
Insider Monkey
Syndax (SNDX) is on the Move, Here's Why the Trend Could be Sustainable
Zacks Investment Research
Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates
Zacks Investment Research
Biotech Is Ripe for M&A. These May Be the Next Acquisition Targets. - Barron's
Barron's
Syndax Revumenib effect R/R KMT2A-rearranged acute leukaemia - Clinical Trials Arena
Clinical Trials Arena
With 85% ownership of the shares, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is heavily dominated by ... - Yahoo Finance
Yahoo Finance
What's Going On With Leukemia-Focused Syndax Pharmaceuticals (SNDX) Stock Today? - Syndax Pharmaceuticals - Benzinga
Benzinga
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab ... - Business Wire
Business Wire
Syndax Pharmaceuticals Inc (SNDX) Reports Q3 2023 Financial Results - Yahoo Finance
Yahoo Finance
Ahead in menin inhibitor race, Syndax plans FDA filing in high-risk leukemias this year - BioWorld Online
BioWorld Online
Kapitalisierung:
|
Volumen (24h):